Loading organizations...
SceneRay has raised $19.0M across 1 funding round.
SceneRay has raised $19.0M in total across 1 funding round.
SceneRay has raised $19.0M in total across 1 funding round.
SceneRay's investors include Qiming Venture Partners.
SceneRay is a technology company specializing in medical imaging and clinical application solutions, primarily serving healthcare providers and patients. It develops advanced imaging systems and software designed to improve diagnostic accuracy and patient care, addressing challenges in medical diagnostics and treatment monitoring. The company has demonstrated growth momentum through ongoing product development and expanding clinical applications, contributing to improved healthcare outcomes[5][6].
SceneRay was founded by a team with strong backgrounds in medical technology and clinical research. The idea emerged from the founders’ recognition of the need for more precise and accessible imaging tools in healthcare. Early traction came from successful clinical applications and partnerships that validated the effectiveness of their imaging solutions in real-world medical settings, helping to establish credibility and market presence[5][6].
SceneRay rides the growing trend of digital transformation in healthcare, particularly the integration of advanced imaging and AI-driven diagnostics. The timing is favorable due to increasing demand for precision medicine and non-invasive diagnostic tools. Market forces such as aging populations, rising chronic diseases, and healthcare digitization work in their favor. SceneRay influences the broader ecosystem by enabling better clinical decisions and fostering innovation in medical imaging technologies[5][6].
Looking ahead, SceneRay is poised to expand its product portfolio and deepen clinical partnerships, leveraging advances in AI and imaging hardware. Trends such as personalized medicine and telehealth will shape their journey, potentially broadening their influence in global healthcare. Their continued focus on innovation and clinical validation positions them to play a significant role in the future of medical diagnostics, tying back to their mission of improving patient outcomes through technology[5][6].
SceneRay has raised $19.0M across 1 funding round. Most recently, it raised $19.0M Series C in July 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2017 | $19.0M Series C | Qiming Venture Partners |